73 filings
Page 2 of 4
8-K
2w09r072ccvf
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
tov0mb
19 Aug 22
Other Events
8:39am
8-K
75g35tqvwoi
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
ukkaykn
12 Aug 22
UNITY Biotechnology, Inc. Reports Second Quarter 2022
7:15am
8-K
3j97dw
5 Jul 22
Other Events
4:01pm
8-K
shis40r
27 Jun 22
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
nqia8y c3s5reo5
7 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
5xnh5 0dh
26 May 22
UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors
9:00am
8-K
rla gwb1r40tbgjmr
10 May 22
UNITY Biotechnology, Inc. Reports First Quarter 2022
4:01pm
8-K
scvei9o39girznde
1 Apr 22
Departure of Directors or Certain Officers
4:02pm
8-K
cf90jgf1
15 Mar 22
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
8:05am
8-K
r6980r
3 Feb 22
UNITY Biotechnology Announces Restructuring to Advance Corporate Strategy and Focus on Key Ophthalmology Programs
4:06pm
8-K
bnlppuc7b0
20 Dec 21
Other Events
8:07am
8-K
hfvuv bdg4x6fhjs6dfh
15 Dec 21
Entry into a Material Definitive Agreement
4:05pm
8-K
oovusrar
10 Nov 21
UNITY Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates
8:05am
8-K
ultdj99 xjl
29 Sep 21
Entry into a Material Definitive Agreement
5:26pm
8-K
t70lo3sd435
10 Aug 21
UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business Updates
4:05pm
8-K/A
2d2dao veg
7 Jul 21
Financial Statements and Exhibits
8:00am
8-K
oiovhl f6
6 Jul 21
UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease
7:11am
8-K
uhxkatube 85m
24 Jun 21
Submission of Matters to a Vote of Security Holders
4:27pm